1. Home
  2. NRXP vs OPAL Comparison

NRXP vs OPAL Comparison

Compare NRXP & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • OPAL
  • Stock Information
  • Founded
  • NRXP 2015
  • OPAL 1998
  • Country
  • NRXP United States
  • OPAL United States
  • Employees
  • NRXP N/A
  • OPAL 342
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • OPAL Natural Gas Distribution
  • Sector
  • NRXP Health Care
  • OPAL Utilities
  • Exchange
  • NRXP Nasdaq
  • OPAL Nasdaq
  • Market Cap
  • NRXP 58.5M
  • OPAL 65.5M
  • IPO Year
  • NRXP N/A
  • OPAL N/A
  • Fundamental
  • Price
  • NRXP $2.84
  • OPAL $2.12
  • Analyst Decision
  • NRXP Strong Buy
  • OPAL Sell
  • Analyst Count
  • NRXP 5
  • OPAL 4
  • Target Price
  • NRXP $31.40
  • OPAL $2.81
  • AVG Volume (30 Days)
  • NRXP 562.9K
  • OPAL 122.7K
  • Earning Date
  • NRXP 08-18-2025
  • OPAL 11-06-2025
  • Dividend Yield
  • NRXP N/A
  • OPAL N/A
  • EPS Growth
  • NRXP N/A
  • OPAL N/A
  • EPS
  • NRXP N/A
  • OPAL 0.06
  • Revenue
  • NRXP N/A
  • OPAL $329,933,000.00
  • Revenue This Year
  • NRXP N/A
  • OPAL $21.15
  • Revenue Next Year
  • NRXP $231.16
  • OPAL $18.76
  • P/E Ratio
  • NRXP N/A
  • OPAL $37.37
  • Revenue Growth
  • NRXP N/A
  • OPAL 12.22
  • 52 Week Low
  • NRXP $1.10
  • OPAL $1.26
  • 52 Week High
  • NRXP $6.01
  • OPAL $4.11
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 56.21
  • OPAL 33.99
  • Support Level
  • NRXP $2.26
  • OPAL $2.28
  • Resistance Level
  • NRXP $2.81
  • OPAL $2.46
  • Average True Range (ATR)
  • NRXP 0.23
  • OPAL 0.11
  • MACD
  • NRXP 0.04
  • OPAL -0.01
  • Stochastic Oscillator
  • NRXP 78.38
  • OPAL 8.11

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

Share on Social Networks: